Overview

Vildagliptin and the Glucagon Response to Hypoglycemia in Type 1 Diabetes

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The study examines whether DPP-4 inhibition by vildagliptin affects the glucagon counterregulatory response to hypoglycemia in type 1 diabetes.
Phase:
Phase 4
Details
Lead Sponsor:
Lund University
Treatments:
Glucagon
Glucagon-Like Peptide 1
Vildagliptin